Orion Corporation will publish its 2007 Financial Statement release on Thursday, 7 February 2008 at 8.30 Finnish time (6.30 am GMT). The release and presentation material will be available after publishing on the Group's homepage at www.orion.fi/investors. Press conference in Finnish at 10.00 EET (8.00 GMT) A press conference will be held on Thursday, 7 February 2008 starting at 10.00 Finnish time, at the Diana Auditorium, address Erottajankatu 5, Helsinki. Orion's new CEO, Timo Lappalainen will host the event and the language of the conference is Finnish. We kindly ask you to notify your participation in advance by email to corpcom@orion.fi or by phone +358 10 426 3504. The event can be followed on-line via Orion's Finnish homepage at www.orion.fi as well as via the Kauppalehti Live web service at www.kauppalehti.fi/live. English version of the conference will be available as an on-demand webcast recoding. The archived webcasts will be available at www.orion.fi/investors (in English) and at www.orion.fi/sijoittajille (in Finnish) later the same day. The English webcast can also be accessed via Thomson's web pages at www.earnings.com and www.streetevents.com. Teleconference in English at 17.00 EET (15.00 GMT) A teleconference in English will be hosted on Thursday, 7 February 2008 starting at 17.00 Finnish time (15.00 GMT). Directions for participating the conference will provided at www.orion.fi/investors during the week 5. Silent period The silent period preceding the publication of the result is ongoing and continues until the disclosure. Orion Corporation Timo Lappalainen Jari Karlson CEO CFO For further information, kindly contact: Susanna Siira, Investor Relations Manager, tel +358 10 426 2782 Publisher: Orion Corporation www.orion.fi Orion is a European pharmaceutical and diagnostics company which emphasises the development of innovative medicinal treatments and diagnostic tests for global markets. Orion develops, manufactures and markets pharmaceuticals for humans and animals, active pharmaceutical ingredients as well as diagnostic tests. Orion's clientele consists mainly of healthcare service providers and professionals. The Group's net sales in 2006 (proforma) were EUR 641.1 million and in the end of 2006 there were 3 061 employees working for the Group. Orion's stocks are listed in OMX Nordic Exchange Helsinki.
Orion Corporation publishes 2007 Financial Statement release on 7 Feb 2008 at 8.30 EET
| Source: Orion